Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
D000284:Administration, Oral; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000188:drug therapy*; D001809:Blood Viscosity; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007383:Intermittent Claudication / Q000097:blood / Q000188:drug therapy; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D011759:Pyrrolidines / Q000008:administration & dosage / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D007773:Lactates; D011759:Pyrrolidines; D014665:Vasodilator Agents; D019344:Lactic Acid; C010651:buflomedil